Skip to content
10-Q

Quarterly Report

TRIUS THERAPEUTICS INC

0001193125-13-207438

← back to feed
Filed
May 8, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 1, 2013 47.87M sh
Capex Q1 2013 · Mar 31, 2013 $8K
Capex Q1 2013 · Mar 31, 2012 $180K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$13.94M
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$10.72M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $20.09M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $16.37M
Cash And Equivalents Q1 2013 · Mar 31, 2012 $10.81M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $11.38M
Current Liabilities Q1 2013 · Mar 31, 2013 $17.55M
Current Liabilities Q1 2013 · Dec 31, 2012 $18.49M
Current Assets Q1 2013 · Mar 31, 2013 $88.68M
Current Assets Q1 2013 · Dec 31, 2012 $73.98M
Total Assets Q1 2013 · Mar 31, 2013 $89.82M
Total Assets Q1 2013 · Dec 31, 2012 $75.27M
Eps Basic Q1 2013 · Mar 31, 2013 −$0.38
Eps Basic Q1 2013 · Mar 31, 2012 −$0.22
Sga Expense Q1 2013 · Mar 31, 2013 $4.5M
Sga Expense Q1 2013 · Mar 31, 2012 $3M
Rd Expense Q1 2013 · Mar 31, 2013 $12.55M
Rd Expense Q1 2013 · Mar 31, 2012 $16.85M
Net Income Q1 2013 · Mar 31, 2013 −$17.28M
Net Income Q1 2013 · Mar 31, 2012 −$7.6M
Operating Income Q1 2013 · Mar 31, 2013 −$15.32M
Operating Income Q1 2013 · Mar 31, 2012 −$10.02M
Revenue Q1 2013 · Mar 31, 2013 $1.73M
Revenue Q1 2013 · Mar 31, 2012 $9.83M